Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal versus subcutaneous regular human insulin or insulin lispro for postprandial glucose control in type 1 diabetes
2007-003924-39Phase 2Completed
- Sponsor
- BD
- Start
- Feb 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of human insulin in diabetes mellitus type 1 (T1D) (4 arms), sponsored by BD. Primary endpoints: Blood glucose AUC 0 to 1.5 hours after meal and Blood glucose AUC 0 to 1.5 hours after meal with baseline correction. Started Feb 2008; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2007-003924-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003924-39.